Signs & Symptoms of Dextromethorphan Exposure From
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine1
0022-3565/97/2802-0941$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 280, No. 2 Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. JPET 280:941–947, 1997 Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine1 TERRI TARASKA and KEVIN T. FINNEGAN Departments of Psychiatry (T.T., K.T.F.), Pharmacology and Toxicology (K.T.F.) and Neuroscience (K.T.F.), University of Utah School of Medicine and the Veterans Administration Medical Center, Salt Lake City, Utah Accepted for publication October 21, 1996 ABSTRACT The role of nitric oxide (NO) in the long-term, amine-depleting antagonized the hyperthermic effects of METH, reducing co- effects of methamphetamine (METH) and 3,4-methyl- lonic temperatures in mice by a mean of 3°C, in comparison enedioxymethamphetamine (MDMA) was investigated in the with control. Moreover, if the hypothermic effects of L-NAME in rodent central nervous system. The NO synthase inhibitor NG- METH-treated mice were prevented by raising the ambient nitro-L-arginine methyl ester (L-NAME) antagonized the dopa- room temperature, the dopamine-depleting actions of the stim- mine- and serotonin-depleting effects of both METH and ulant were fully restored. The latter findings suggest that it is the MDMA. The protective actions of L-NAME in METH-treated hypothermic actions of L-NAME, rather than its NO inhibitory mice were reversed by prior administration of the NO generator properties, that are responsible for the prevention of neurotox- G G isosorbide dinitrate. However, pretreatment with N -mono- icity. -
MDMA and Sexual Behavior
Note: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Substance Use & Misuse following peer review. The definitive publisher-authenticated version [McElrath K (2005) MDMA and sexual behavior: ecstasy users’ perceptions about sexuality and sexual risk, Substance Use & Misuse, 40:9, 1461-1477] is available online at http://www.informaworld.com/smpp/title~db=all~content=g714012467 MDMA and Sexual Behavior: Ecstasy Users’ Perceptions About Sexuality and Sexual Risk KAREN MCELRATH School of Sociology and Social Policy, Belfast, Ireland Published in Substance Use & Misuse,(2005) 40:9,1461—1477 This study examines the relationship between MDMA (Ecstasy), sexual behavior, and sexual risk taking. The sample consisted of 98 current and former users of MDMA. Several strategies were utilized to recruit respondents and data were collected through in-depth interviews during 1997 and 1998. The majority of respondents had used MDMA during the 6-month period prior to the interview and a large percentage had consumed the drug on 100 occasions or more. Most respondents reported feelings of emotional closeness while consuming MDMA but without the desire for penetrative sex. Others, however, reported that MDMA increased sexual arousal and some respondents (in particular gay and bisexual females) had used MDMA specifically for sexual enhancement. Sexual risk taking (e.g., having multiple partners, engaging in sex without a condom) was prevalent among respondents who did engage in sexual activity during MDMA episodes. Explanations for the findings are offered and implications for prevention/intervention are discussed. Keywords MDMA; ecstasy; sexual behavior Introduction Although a patent for 3,4-methylenedioxymethamphetamine (MDMA) was issued in 1914 (Shulgin, 1986), “recreational”a use of the drug did not surface until the 1970s and 1980s, and for the most part was restricted to selected regions in the U.S. -
MDMA ('Ecstasy'): a Review of Its Harms and Classification Under the Misuse of Drugs Act 1971
MDMA (‘ecstasy’): A REVIEW OF ITS HARMS AND CLASSIFICATION UNDER THE MISUSE OF DRUGS ACT 1971 Advisory Council on the Misuse of Drugs ACMD Advisory Council on the Misuse of Drugs 3rd Floor (SW), Seacole Building 2 Marsham Street London SW1P 4DF February 2008 Rt Hon Jacqui Smith MP Home Office 2 Marsham Street London SW1P 4DF Dear Home Secretary, The Advisory Council on the Misuse of Drugs (ACMD) recently considered that a review of MDMA (‘ecstasy’) would be timely as there is a much greater body of evidence regarding the harms and misuse of MDMA since the Council last provided its advice to Ministers in 1996. I have pleasure in enclosing the Council’s report. The use of MDMA is undoubtedly harmful. I would therefore like to emphasise that the Council continues to be concerned about the widespread use of MDMA; particularly among young people. Due to its prevalence of use, MDMA is a significant public health issue and we believe that criminal justice measures will only have limited effect. You will wish to note that the Council strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health. Forensic evidence shows that MDMA is by far the most commonly seized of the ‘ecstasy-like’ drugs. MDMA is presently generically classified in Class A under the Misuse of Drugs Act with other ‘ecstasy-like’ drugs. The ACMD has not extended this review to other compounds within the generic classification since their use is considerably less than that of MDMA. -
Phencyclidine: an Update
Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V. -
Motor Delays in MDMA (Ecstasy) Exposed Infants Persist to 2 Years
Neurotoxicology and Teratology 54 (2016) 22–28 Contents lists available at ScienceDirect Neurotoxicology and Teratology journal homepage: www.elsevier.com/locate/neutera Motor delays in MDMA (ecstasy) exposed infants persist to 2 years Lynn T. Singer a,⁎, Derek G. Moore b,MeeyoungO.Mina, Julia Goodwin b, John J.D. Turner b, Sarah Fulton a,AndrewC.Parrottc a Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States b The University of East London, Docklands Campus, University Way, London E16 2RD, United Kingdom c Swansea University, Singleton Park, Swansea, Wales SA2 8PP, United Kingdom, article info abstract Article history: Background: Recreational use of 3,4 methylenedioxymethamphetamine (ecstasy, MDMA) is increasing world- Received 29 July 2015 wide. Its use by pregnant women causes concern due to potentially harmful effects on the developing fetus. Received in revised form 5 January 2016 MDMA, an indirect monoaminergic agonist and reuptake inhibitor, affects the serotonin and dopamine systems. Accepted 20 January 2016 Preclinical studies of fetal exposure demonstrate effects on learning, motor behavior, and memory. In the first Available online 21 January 2016 human studies, we found prenatal MDMA exposure related to poorer motor development in the first year of life. In the present study we assessed the effects of prenatal exposure to MDMA on the trajectory of child devel- Keywords: opment through 2 years of age. We hypothesized that exposure would be associated with poorer mental and Behavior Cocaine motor outcomes. Alcohol Materials and Methods: The DAISY (Drugs and Infancy Study, 2003–2008) employed a prospective longitudinal Teratology cohort design to assess recreational drug use during pregnancy and child outcomes in the United Kingdom. -
Recreational Drug Use: What’S the Harm?
Your Employee and Family Assistance Program is a support service that can help you take the first step toward change. Recreational drug use: what’s the harm? Recreational drug use can be defined as the use of drugs strictly for pleasure, and quite often in social situations. Recreational users are not necessarily physically or psychologically dependent on drugs, however these users do run the risk of developing a dependency. There is considerable controversy surrounding the use of drugs, and opinions vary widely from those who think all drugs should be illegal, to those who advocate for the legalization of certain drugs. Even though it is illegal to use drugs such as marijuana, cocaine, LSD, ecstasy, and amphetamines, those who choose to use these substances can find them quite readily. And many—both young and old—believe there is little or no harm to using these drugs recreationally. Why use? Recreational drug users find that using drugs, from marijuana to cocaine, can help them: improve their mood, increase excitement and enjoyment, reduce inhibitions, become more relaxed, and achieve social acceptance among their peers. These benefits are generally reported to be immediate and short-term. The negative consequences of recreational drug use, on the other hand, tend to be delayed and longer term. Escalation Any recreational drug user risks escalation of their drug use, which in turn may develop into a drug dependency. Drug use and the problems associated with it may start off as limited or small, but gradually escalate to causing bigger problems in more areas of the user's life. -
Introduced B.,Byhansen, 16
LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. -
Bath Salts”: Synthetic Psychostimulants and Hallucinogens Silas W
“E” to “Bath Salts”: Synthetic Psychostimulants and Hallucinogens Silas W. Smith, MD, FACEP CSAM. Addiction Medicine Review Course 2014. September 6, 2014 REFERENCES Presentation Bialer PA. Designer drugs in the general hospital. Psychiat Clin N Am. 2002;25:231-43. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila). 2008;46:146-52. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103:1048-50. Braden MR, Parrish JC, Naylor JC, Nichols DE. Molecular interaction of serotonin 5- HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol. 2006;70:1956-64. Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 2011;6:e21917. Center for Substance Abuse Treatment, SAMHSA. Inhalants. Substance Abuse Treatment Advisory. March 2003;3(1):1-8. Chambers JJ, Kurrasch-Orbaugh DM, Parker MA, Nichols DE. Enantiospecific Synthesis and Pharmacological Evaluation of a Series of Super-Potent, Conformationally Restricted 5-HT2A/2C Receptor Agonists. J Med Chem. 2001;44:1003-10. Cohen BMZ, Butler R. BZP-party pills: A review of research on benzylpiperazine as a recreational drug. Int J Drug Policy. 2011;22:95-101. Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther. -
Substance Misuse: Result of Stress (Physical Or Emotional) Or Fatigue, Are Fungi Containing the Chemical Psilocybin
Clinical sweating, numbness, confusion and difficulty Magic mushrooms concentrating. Longer term, flashbacks may In addition to their most common title, magic occur, during which the user re-experiences the mushrooms go by a wide range of names Module 1982 trip days, months or even years later, perhaps including Shrooms, Mushies, Magics, Liberties, following subsequent drug use but also as a Philosopher’s Stones, Amani and Agarics. They Substance misuse: result of stress (physical or emotional) or fatigue, are fungi containing the chemical psilocybin. which can trigger severe anxiety or paranoia. This pro-drug is converted in the body to hallucinogenics Tolerance can develop rapidly, and psychological psilocin, which has psychoactive properties. – though not physical – dependence can occur.1 Although there are over 180 psilocybin- From this CPD module you will learn: containing mushrooms found across the world, Substances the most commonly used in the UK is Psilocybe • What a hallucinogenic drug is, how they exert their effects and the This learning module will focus on magic semilanceata, a small, light brown mushroom risks associated with their use mushrooms and lysergic acid diethylamide, more known as the liberty cap. There is also the more • Detailed information about the two most used hallucinogens, magic commonly known as LSD, as these are the two potent Amanita muscaria, also known as the mushrooms and LSD hallucinogenic drugs widely used recreationally. fly agaric, which resemble the red and white It is worth noting that psychedelic drug use toadstools of fairy tales, though this contains • Some of the less commonly used psychedelic drugs appeared to increase during the COVID-19 additional psychoactive chemicals such as • Some relevant harm reduction measures for hallucinogenics pandemic, while use of substances such as ibotenic acid and muscimol which can cause ecstasy and nitrous oxide fell, in all likelihood delirium, drooling, dizziness and vomiting as well because these are more associated with highly as convulsions. -
Mental Health Effects of Recreational Drugs and Alcohol Understanding
Understanding the mental health effects of recreational drugs and alcohol understanding mental health effects of recreational drugs and alcohol 1 Understanding the mental health effects of recreational drugs and alcohol This booklet is for anyone who wants to know more about the mental health effects of recreational drugs and alcohol. It explains how drugs and alcohol affect mental health, and what might happen if you use recreational drugs and have a mental health problem. It also provides information on what support is available and guidance for friends and family. Contents What are recreational drugs and alcohol? 4 How can recreational drugs affect mental health? 5 What types of drugs are there? 8 What effect could different drugs have? 11 Can recreational drugs and medication affect each other? 32 What support is available? 36 What help is available if I have a dual diagnosis? 38 How can family and friends help? 42 Useful contacts 45 3 Understanding the mental health effects of recreational drugs and alcohol What are recreational drugs and alcohol? Drugs are substances people take: • to give themselves a pleasurable experience • to help them feel better if they are having a bad time • because their friends are using them • to see what it feels like. They include alcohol, tobacco (nicotine), substances such as cannabis, heroin, cocaine and ecstasy, and some prescribed medicines. All my experiences with recreational drug use started due to social influences, of wanting to 'fit in'. Recreational drugs may be: • legal – such as nicotine and alcohol • illegal – this means it is against the law to have them or supply them to other people; most recreational drugs are illegal • controlled – these are drugs used in medicine, such as benzodiazepines; it is legal to take controlled drugs if a doctor has given you a prescription for them but it is illegal to have them if not; it is also illegal to give or sell controlled drugs to anyone else. -
The Joint French-US Seminar on Phencyclidine and Related
TIPS deptember 1983 363 p-Amin&mmcacid 1 Dihydmplertdtns 1 Dihydmiok acid ’ J Lsym- I I 1 Dit-rfdrotolkacid ) I The joint French-US seminar on Tetrahydroblic acid phencyclidine and related arylcyclohexylamines Protein syllth8sis A joint French-US seminar was held at La (tram OH/N) one of the most potent opioid Grande Motte (Montpellier) France, 20-24 analgesics known. Removal of the oxygen September 1982, to assess the current sci- group in this series produces compounds entific status of phencyclidine (PCP) and with PCP-like activity to varying degrees. related arylcyclohexylamines. The seminar Zimmerman and associates (Lilly) reported L______--:-______I was attended by 58 scientists interested in the discovery and characterization of a new Fig. 5. Flow diagram of purim,thymidine and pro- the chemistry, biochemistry, pharmacol- series of benzo(f)isoquinoline derivatives rein synthesis. ogy, therapeutic applications and drug that have stimulus discriminative properties abuse aspects of arylcyclohexylamines. similar to PCP. One of the most potent is problems presented and the management of Thirty-four American, 19 French, 3 Japan the methylcyclopropyl bridged iso research show important differences, it is ese, 1 British and 1 Israeli investigator quinoline, LY 154045. PCP-like effects essential that industry continues to recruit attended, representing each of the above were maximized with a hydroxyl sub its proper proportion of the available talent. major disciplines. The organizing commit- stituent in the aromatic ring. Medawar has commented that the ordi- tee consisted of E. F. Domino of the Uni- One of the major questions in PCP nary processes of scientific discovery are versity of Michigan and P. -
1 Dextromethorphan and Dextrorphan Influence Insulin Secretion By
JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted. The final version may differ from this version. JPET # 265835 Dextromethorphan and dextrorphan influence insulin secretion by interacting with 2+ KATP and L-type Ca channels in pancreatic β-cells Anne Gresch, Martina Düfer University of Münster, Pharmaceutical and Medicinal Chemistry, Dept. of Pharmacology, Corrensstraße 48, 48149 Münster, Germany Downloaded from jpet.aspetjournals.org at ASPET Journals on September 30, 2021 1 JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted. The final version may differ from this version. JPET # 265835 Running Title: NMDA receptor antagonists and β-cells Section assignment for table of contents: Endocrine and Diabetes Address correspondence to: Prof. Dr. Martina Düfer Pharmaceutical and Medicinal Chemistry, Dept. of Pharmacology PharmaCampus Corrensstraße 48, 48149 Münster, Germany Downloaded from Phone: +49 251 83 33339; Fax: +49 251 83 32144 [email protected] jpet.aspetjournals.org Text pages: 18 Tables: 0 at ASPET Journals on September 30, 2021 Figures: 6 References: 42 Word count: Abstract: 250 Introduction: 614 Discussion: 1712 Key words: β-cell, cytosolic calcium, dextromethorphan, insulin secretion, NMDA receptor, KATP channel Abbreviations: a.u.: arbitrary fluorescence units, DXM: dextromethorphan, DXO: dextrorphan, FOPP: fraction of plateau phase, MEA: microelectrode array, NMDA: N-methyl- D-aspartate, SUR1-KO: sulfonylurea receptor 1 knockout 2 JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted.